Ashleigh Palmer, President & CEO at UNIGENE LABORATORIES INC (UGNE), bought 21,200 shares at $0.80 ($17K) on 2010-06-18, disclosed to the SEC on 2010-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.77 | 2,500 | $2K | 11.4% |
| 2 | $0.80 | 18,700 | $15K | 88.6% |
| Total | $0.80 avg | 21,200 | $17K | 100% |
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |